Contact
Please use this form to send email to PR contact of this press release:
Innovation Pharmaceuticals Announces New Milestone at BeaMed; On Track to File 510(k) Submission to FDA in Q2 2024
TO:
Please use this form to send email to PR contact of this press release:
Innovation Pharmaceuticals Announces New Milestone at BeaMed; On Track to File 510(k) Submission to FDA in Q2 2024
TO: